VACCELERATE Latest News

Conclusion of EU Funding for VACCELERATE

The EU-funded VACCELERATE project has officially come to an end, marking the completion of a groundbreaking pan-European initiative. Over its duration, VACCELERATE has significantly contributed to the advancement of vaccine research and clinical trial coordination across Europe. Through collaboration, innovation, and strategic infrastructure development, the project has established a lasting impact on pandemic preparedness and public health.

Key Achievements:

1. Establishment of a Pan-European Clinical Trial Network
A robust and interconnected network of clinical trial sites was developed across Europe and associated countries, improving coordination and fostering collaboration among researchers, institutions, and stakeholders.

2. Acceleration of (Vaccine) Trials
By facilitating rapid access to trial sites, expert teams, and harmonized protocols, VACCELERATE played a crucial role in expediting (vaccine) trials. This ensured the timely generation of reliable data for critical decision-making during the COVID-19 pandemic.

3. Citizen Engagement in (Vaccine) Research
Innovative strategies were implemented to involve the public in (vaccine) research. The establishment of the Volunteer Registry enabled individuals to participate in clinical trials, significantly boosting recruitment and raising awareness of vaccine development.

4. Data Harmonization and Standardization
Through the creation of standardized protocols and data-sharing mechanisms, VACCELERATE improved the quality and comparability of clinical trial data. By embracing the FAIR principles, the project laid the foundation for future multinational studies.

5. Training and Capacity Building
Comprehensive training programs for clinical researchers and their teams strengthened expertise in vaccine trials across Europe, enhancing the readiness of clinical sites for future pandemics.

6. Contribution to Public Health
VACCELERATE’s research included studies on vaccines in under-researched populations, such as the very old and very young, as well as assessments of optimal booster vaccination timing for the general population. These efforts will continue to support global health initiatives in the future.

VACCELERATE has demonstrated the power of collaboration and innovation in addressing global health challenges. By fostering shared resources and expertise, the project has set new standards for vaccine research and pandemic preparedness in Europe. The infrastructure established will continue to support future research and public health initiatives, ensuring long-term benefits beyond the project’s duration.

Probandinnen und Probanden gesucht in Heidelberg!

VACCELERATE Newsletters

We are happy to send you the pdf versions of our newsletters including the links providing further information on the topics: info@vaccelerate.eu. 

NEWSLETTER Issue I/2025

Published in February 2025

NEWSLETTER Issue III/2024

Published in December 2024.

NEWSLETTER Issue II/2024

Published in September 2024.

NEWSLETTER Issue I/2024

Published in March 2024.

NEWSLETTER Issue IV/2023

Published in December 2023.

NEWSLETTER Issue III/2023

Published in September 2023.

NEWSLETTER Issue II/2023

Published in June 2023.

NEWSLETTER Issue I/2023

Published in March 2023.

NEWSLETTER Issue III/2022

Published in December 2022. 

NEWSLETTER Issue II/2022

Published in September 2022. 

NEWSLETTER Issue I/2022

Published in July 2022. 

VACCELERATE Press Releases

17.07.2024 / Innovative approach to vaccine trials and pandemic preparedness: https://portal.uni-koeln.de/en/universitaet/aktuell/press-releases/single-news/innovative-approach-to-vaccine-trials-and-pandemic-preparedness

20.04.2024 / Study shows more than half of global infectious diseases experts surveyed rate influenza as the number one pathogen of concern of pandemic potential: https://www.escmid.org/fileadmin/escmid/media/pdf/press_releases/2024/2024-q2/Press_release_20240421_P3133PandemicriskV7.pdf

19.01.2024 / VACCELERATE APT Workshop in Cologne: A paradigm shift towards a learning health system: https://twitter.com/vaccelerate_eu/status/1748405062714441795

12.01.2023 / Would You Take Part in A Clinical Vaccine Trial? A Survey on COVID-19 Vaccine Trial Participation by the EU-funded project VACCELERATE: Willingness to participate in COVID-19 vaccine trials (cleoresearch.org)

19.09.2022 / VACCELERATE Network Supports Diagnostics and Treatment of Monkeypox: https://twitter.com/vaccelerate_eu/status/1571924880295084033

31.08.2022 / EVI's new publication identifies gaps in outreach information on COVID-19 vaccine trials in Europe: https://www.euvaccine.eu/post/evi-to-lead-immune-monitoring-in-pan-european-vaccine-trial-network-vaccelerate

29.08.2022 / Lietuvoje jau veikia VACCELERATE savanorių dalyvauti klinikiniuose tyrimuose registras: https://www.santa.lt/lietuvoje-jau-veikia-vaccelerate-savanoriu-dalyvauti-klinikiniuose-tyrimuose-registras/

25.08.2022 / First children participate in UMC Utrecht-led study: Is one COVID-19 vaccination dose enough for kids? https://twitter.com/vaccelerate_eu/status/1562848995793596416

28.07.2022 / The VACCELERATE Volunteer Clinical Trial Registry is launched in Italy: https://twitter.com/vaccelerate_eu/status/1556578444850434055

21.07.2022 / How many COVID-19 infections are there in Germany? Pilot study in Cologne investigates high dark figure: https://twitter.com/vaccelerate_eu/status/1550014216635023360 (German translation: https://twitter.com/CornelyOliver/status/1550015496413745152)

15.03.2022 / VACCELERATE study on the effectiveness of a second booster shot begins in Ireland: https://twitter.com/vaccelerate_eu/status/1503688207506063360

22.02.2022 / Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier: Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier – Karolinska Universitetssjukhuset (cision.com)

16.02.2022 / Wer sollte wann weiteren Booster bekommen?: https://www.uk-koeln.de/de/uniklinik-koeln/aktuelles/detailansicht/wer-sollte-wann-weiteren-booster-bekommen/

05.11.2021 / Studie zur Wirksamkeit der „Boosterimpfung“ gegen Corona startet: https://portal.uni-koeln.de/universitaet/aktuell/presseinformationen/detail/studie-zur-wirksamkeit-der-boosterimpfung-gegen-corona-startet

22.07.2021 / Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants (European Commission): https://ec.europa.eu/commission/presscorner/detail/en/IP_21_3803

12.04.2021 / Cologne’s university medicine to coordinate EU vaccine research network (Coimbra Group): https://newsletters.coimbra-group.eu/t/ViewEmail/j/4AD409F80C7A2CCF2540EF23F30FEDED/4013911B0F09E5BE4AB3169DA1FD82E9

16.03.2021 COMBACTE To Support Vaccine Trial Network VACCELERATE (Combacte): https://www.combacte.com/news/combacte-support-vaccine-trial-network-vaccelerate/

15.03.2021 / 12 Million for European COVID-19 Vaccine Research (Combacte): https://www.combacte.com/news/12-million-european-covid-vaccine-research/

18.02.2021 / Neues Konsortium koordiniert EU-Impfstoff-Forschungsnetzwerk: https://www.uk-koeln.de/uniklinik-koeln/aktuelles/detailansicht/neues-konsortium-koordiniert-eu-impfstoff-forschungsnetzwerk/

18.02.2021 / Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE (CECAD): https://www.cecad.uni-koeln.de/about/news/article/colognes-university-medicine-to-coordinate-eu-vaccine-research-network-vaccelerate/

17.02.2021 / EVI to lead Immune Monitoring in pan-European vaccine trial network, VACCELERATE: https://www.euvaccine.eu/post/evi-to-lead-immune-monitoring-in-pan-european-vaccine-trial-network-vaccelerate

17.02.2021 / EU to invest €150 million for research to counter coronavirus variants (European Commission): https://ec.europa.eu/info/news/eu-invest-eu150-million-research-counter-coronavirus-variants-2021-feb-17_en

VACCELERATE Press Review

31.10.2024 / Forscher besorgt: Das Ranking mit den gefährlichsten Viren (CHIP): https://www.chip.de/news/Forscher-besorgt-Das-Ranking-mit-den-gefaehrlichsten-Viren_185571513.html

22.07.2024 / Impfstoff: Neue Studienform soll Entwicklung beschleunigen (Ärzteblatt): https://www.aerzteblatt.de/nachrichten/153078/Impfstoff-Neue-Studienform-soll-Entwicklung-beschleunigen

27.05.2024 / Viele schauten hoch – Seltenes Schauspiel am Kölner Abendhimmel – jetzt ist klar, was dahintersteckt (Express): https://www.express.de/koeln/zeppelin-am-koelner-himmel-jetzt-ist-klar-was-dahintersteckt-817913

03.05.2024 / Bármikor kitörhet egy újabb világjárvány (Magyar Hirlap): https://www.magyarhirlap.hu/egeszseg/20240424-barmikor-kitorhet-egy-ujabb-vilagjarvany#google_vignette

28.04.2024 / Researchers warn: These viruses could cause the next pandemic (Breaking Latest News): https://www.breakinglatest.news/health/researchers-warn-these-viruses-could-cause-the-next-pandemic/#google_vignette

25.04.2024 / Грипът се смята за най-голямата пандемична заплаха (Hayka Off News): https://nauka.offnews.bg/meditcina/gripat-se-smiata-za-naj-goliamata-pandemichna-zaplaha-200408.html

24.04.2024 / Cientistas esperam nova pandemia (Terra Brasil Noticias): https://terrabrasilnoticias.com/2024/04/cientistas-esperam-nova-pandemia/

24.04.2024 / El virus que podría causar la próxima pandemia, advierten científicos (TV Azteka): https://www.tvazteca.com/aztecauno/cientificos-advierten-virus-proxima-pandemia-lor-notas-mt

24.04.2024 / ALERTA global: vírus brasileiro pode desencadear a próxima pandemia mundial (ESCOLA educacao): https://escolaeducacao.com.br/alerta-global-virus-brasileiro-pode-desencadear-a-proxima-pandemia-mundial/

23.04.2024 / Influenza is considered the biggest pandemic threat (Earth): https://www.earth.com/news/influenza-is-considered-the-biggest-pandemic-threat/

23.04.2024 / Influenza is the most dangerous pandemic threat, according to infectious disease experts (Motions Online): https://www.motionsonline.org/education/influenza-is-the-most-dangerous-pandemic-threat-according-to-infectious-disease-experts/57/

23.04.2024 / Expertos señalan a la influenza como protagonista de la próxima pandemia (Webconsultas): https://www.webconsultas.com/noticias/salud-al-dia/gripe/expertos-senalan-a-la-influenza-como-protagonista-de-la-proxima-pandemia

23.04.2024 / Influenza e SARS tra i più probabili responsabili di future pandemie secondo gli esperti (Doctor 33): https://www.doctor33.it/articolo/60641/influenza-e-sars-tra-i-piu-probabili-responsabili-di-future-pandemie-secondo-gli-esperti

23.04.2024 / Após estudos, cientistas alertam para possibilidade de ‘nova pandemia’ (Portal Da Cidade): https://uniaodavitoria.portaldacidade.com/noticias/saude/apos-estudos-cientistas-alertam-para-possibilidade-de-nova-pandemia-5845

23.04.2024 / Nyilvánosságra hoztak egy listát a vírusokról, amelyek bármikor világjárványt okozhatnak (SMSZ Press): https://szmsz.press/2024/04/23/nyilvanossagra-hoztak-egy-listat-a-virusokrol-amelyek-barmikor-vilagjarvanyt-okozhatnak/

22.04.2024 / Cientistas fazem ALERTA sobre qual VÍRUS deve causar próxima PANDEMIA; SAIBA QUAL Portal de Prefeitura): https://portaldeprefeitura.com.br/uncategorized/cientistas-fazem-alerta-sobre-qual-virus-deve-causar-proxima-pandemia-saiba-qual/

22.04.2024 / Após estudos, cientistas alertam para possibilidade de ‘nova pandemia’ (nd+): https://ndmais.com.br/saude/apos-estudos-cientistas-alertam-para-possibilidade-de-nova-pandemia/

22.04.2024 / A próxima pandemia que pode assolar o mundo provavelmente surgirá de uma variante ou mutação do vírus influenza (Gazeta de Varginha): https://www.gazetadevarginha.com.br/post/a-pr%C3%B3xima-pandemia-que-pode-assolar-o-mundo-provavelmente-surgir%C3%A1-de-uma-variante-ou-muta%C3%A7%C3%A3o-do-v%C3%ADru

22.04.2024 / Gripa, principalul agent patogen cu potențial pandemic. Ce spun experții mondiali (360 Medical): https://360medical.ro/stiri/gripa-principalul-agent-patogen-cu-potential-pandemic-ce-spun-expertii-mondiali/2024/04/22/

22.04.2024 / Expertos apuntan a la gripe como el patógeno con mayor potencial pandémica (Infosalus): https://www.infosalus.com/salud-investigacion/noticia-expertos-apuntan-gripe-patogeno-mayor-potencial-pandemica-20240422080449.html

22.04.2024 / Новая пандемия может начаться в мире из-за гриппа (Teleport 2001): https://www.teleport2001.ru/news/2024-04-22/181573-novaya-pandemiya-mozhet-nachatsya-v-mire-iz-za-grippa.html

22.04.2024 / Vírus conhecido pode causar a próxima pandemia, alertam cientistas (Terra): https://www.terra.com.br/vida-e-estilo/saude/virus-conhecido-pode-causar-a-proxima-pandemia-alertam-cientistas,3d23abec4196fcd7c52efa4fdd37328cu5qr3kjk.html#google_vignette

22.04.2024 / Influenza hat laut Experten von allen Erregern das größte Pandemie-Potenzial (MDR): https://www.mdr.de/wissen/medizin-gesundheit/influenza-hat-groesstes-pandemie-potenzial-100.html

22.04.2024 / Flu most likely virus to cause next pandemic, experts warn (Independent): https://www.independent.ie/irish-news/health/flu-most-likely-virus-to-cause-next-pandemic-experts-warn/a992672449.html

22.04.2024 / Estudo aponta alta chance de nova pandemia de Influenza Vale 24 Horas): https://vale24horas.com.br/noticia/8260/estudo-aponta-alta-chance-de-nova-pandemia-de-influenza

21.04.2024 / ESCMID: грипп — самый опасный вирус по пандемическому потенциалу (Planet Today): https://planet-today.ru/novosti/nauka/item/166437-escmid-gripp-samyj-opasnyj-virus-po-pandemicheskomu-potentsialu

21.04.2024 / آنفولانزا در صدر بزرگترین بیماری‌های فراگیر جهان (Technoc): https://technoc.ir/%D8%A2%D9%86%D9%81%D9%88%D9%84%D8%A7%D9%86%D8%B2%D8%A7-%D8%AF%D8%B1-%D8%B5%D8%AF%D8%B1-%D8%A8%D8%B2%D8%B1%DA%AF%D8%AA%D8%B1%DB%8C%D9%86-%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C%D9%87%D8%A7%DB%8C/

21.04.2024 / Influenza pode causar proxima pandemia diz estudo (Valor): https://valor.globo.com/brasil/noticia/2024/04/22/influenza-pode-causar-proxima-pandemia-diz-estudo.ghtml

21.04.2024 / Expertos califican a la influenza como principal riesgo pandemico (Notipress): https://notipress.mx/vida/expertos-califican-a-la-influenza-como-principal-riesgo-pandemico-21166

21.04.2024 / Cientistas fazem alerta sobre qual vírus deve causar próxima pandemia (Oglobo): https://oglobo.globo.com/saude/noticia/2024/04/21/cientistas-fazem-alerta-sobre-qual-virus-deve-causar-proxima-pandemia.ghtml

21.04.2024 / Influenza pode causar proxima pandemia diz estudo (Valor): https://valor.globo.com/brasil/noticia/2024/04/22/influenza-pode-causar-proxima-pandemia-diz-estudo.ghtml

21.04.2024 / ALERTA: Cientistas apontam qual vírus deve causar a próxima pandemia (Terra Brasil Noticias): https://terrabrasilnoticias.com/2024/04/alerta-cientistas-apontam-qual-virus-deve-causar-a-proxima-pandemia/

21.04.2024 / New study rates influenza as the top pandemic threat, here’s why (Intersting Engineering): https://interestingengineering.com/science/influenza-top-pandemic-threat-survey

21.04.2024 / Preparando armas contra la proxima pandemia (Press Reader): https://www.pressreader.com/spain/el-mundo-primera-edicion-weekend-int/20240421/282076281922295

20.04.2024 / Next pandemic likely to be caused by flu virus, scientists warn (The Guardina): https://www.theguardian.com/world/2024/apr/20/next-pandemic-likely-to-be-caused-by-flu-virus-scientists-warn

29.09.2023 / Παρουσίαση αποτελεσμάτων έρευνας από το Eupati Cyprus και το European University με στόχο την ανίχνευση των εκπαιδευτικών αναγκών των ασθενών στην Κύπρο (ANT Live): https://www.ant1live.com/koinonia/562456_paroysiasi-apotelesmaton-ereynas-apo-eupati-cyprus-kai-european-university-me-stoho

29.09.2023 / Παρουσίαση αποτελεσμάτων έρευνας από το Eupati Cyprus και το European University με στόχο την ανίχνευση των εκπαιδευτικών αναγκών των ασθενών στην Κύπρο (Cyprus News): https://cyprusnews.live/article/202463

29.09.2023 / Οι εκπαιδευτικές ανάγκες των ασθενών στην Κύπρο-Τι κατέδειξε έρευνα (In Business News): https://inbusinessnews.reporter.com.cy/article/2023/9/29/734787/oi-ekpaideutikes-anagkes-ton-asthenon-sten-kupro-ti-katedeixe-ereuna/

23.12.2022 / Johanna Massy (64) is 50.000ste vrijwilliger bij Vaccinopolis: “Door deel te nemen hoop ik de wetenschap vooruit te helpen” (HLN): https://www.hln.be/edegem/johanna-massy-64-is-50-000ste-vrijwilliger-bij-vaccinopolis-door-deel-te-nemen-hoop-ik-de-wetenschap-vooruit-te-helpen~affc3851/?referrer=https%3A%2F%2Fmedialibrary.uantwerpen.be%2F

23.11.2022 / Výzkumná síť VACCELERATE: staňte se součástí výzva registru dobrovolníků (MUNI MED): https://www.med.muni.cz/aktuality/vyzkumna-sit-vaccelerate-stante-se-soucasti-vyzva-registru-dobrovolniku

10.10.2022 / Corona-Pandemie wurde zum Booster für Vakzinologie (K.AT News): https://k.at/news/corona-pandemie-booster-fuer-vakzinologie/402175785

20.09.2022 / Η Ελλάδα στον χάρτη των κλινικών δοκιμών εμβολίων κατά της CoViD (Iatronet): https://www.iatronet.gr/article/111645/h-ellada-ston-harth-ton-klinikon-dokimon-emvolion-kata-ths-covid

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (Mattino Verona): https://www.mattinodiverona.it/2022/07/28/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-lunivr-riferimento-nazionale-del-progetto/

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Lafreccia): https://www.lafrecciaweb.it/2022/07/28/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari-progetto-ue-parte-anche-in-italia-universita-verona-centro-di-riferimento-nazionale/

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (In salute news): https://www.insalutenews.it/in-salute/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-universita-di-verona-riferimento-nazionale/

28.07.2022 / Covid: attivo in Italia registro volontari „VACCELERATE“ Database permette di aderire a progretti sul vaccino (Federfarma): https://federfarma.it/Edicola/Ansa-Salute-News/VisualizzaNews.aspx?type=Ansa&key=33884

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Corriere Del Umbria): https://corrieredisiena.corr.it/news/adnkronos/32566212/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari.html

28.07.2022 / L'università di Verona riferimento nazionale del Registro degli studi clinici volontari „VACCELERATE“ (Primoweb): https://primoweb.it/luniversita-di-verona-riferimento-nazionale-del-registro-degli-studi-clinici-volontari-vaccelerate/

28.07.2022 / Arriva in Italia registro die volontari per participare a studi clinici sui vaccini (Veronasera): https://www.veronasera.it/attualita/registro-volontari-vaccini-vaccelerate-28-luglio-2022.html

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Olbia Notizie): https://www.olbianotizie.it/24ore/articolo/632005-partecipare_a_studi_su_prodotti_anti_pandemie_al_via_registro_volontari

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Tiscali News): https://notizie.tiscali.it/salute/articoli/partecipare-studi-prodotti-anti-pandemie-via-registro-volontari-00001/?chn

28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Affaritaliani): https://www.affaritaliani.it/rubriche/tuttasalute/notiziario/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari-277113.html

28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (A Salute & Benessere): https://www.larena.it/rubriche/salute-e-benessere/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-verona-e-capofila-nazionale-1.9543801

26.07.2022 / UMC Utrecht is investigating whether one corona jab in children works just as well as two (Time.News): https://time.news/umc-utrecht-is-investigating-whether-one-corona-jab-in-children-works-just-as-well-as-two/

26.07.2022 / Onderzoek naar 1 of 2 coronaprikken bij kinderen (UMC Utrecht): https://www.umcutrecht.nl/nieuws/onderzoek-naar-1-of-2-coronaprikken-bij-kinderen

27.03.2022 / Antibodies could determine fourth vaccine eligibility – study: https://www.rte.ie/news/coronavirus/2022/0327/1288742-coronavirus-antibodies/

24.01.2022 / VACCELERATE: Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment (THE LANCET Preprint): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4016606

06.01.2022 / Nach dem Booster: Brauchen wir bald noch eine vierte Impfung gegen Corona? (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-dem-booster-brauchen-wir-bald-noch-eine-vierte-impfung-gegen-corona–39359316

19.12.2021 / Die Vierte Impfung. Impfstoff gegen Omikron (Zeit): https://www.zeit.de/gesundheit/2021-12/omikron-variante-impfstoff

13.12.2021 / Mehrere Impfversuche bei initialen Non-Respondern machen“ (Ärzteblatt): https://www.aerzteblatt.de/nachrichten/129957/Mehrere-Impfversuche-bei-initialen-Non-Respondern-machen

08.12.2021 / Interview with Zoi D. Pana about the situation in Cyprus and the VACCELERATE network (Offsite): https://www.offsite.com.cy/eidiseis/topika/pana-gia-vaccelerate-den-kanei-toys-anthropoys-peiramatozoa

03.12.2021 / Interview with Oliver Cornely and Zoi D. Pana (Alpha Channel CY): https://twitter.com/vaccelerate_eu/status/1468558210437165059

23.11.2021 / Interview „Seit März 2020 im Lockdown“ (Kölner Stadt-Anzeiger): Print

15.11.2021 / Lietuvoje pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Lrytas): https://www.lrytas.lt/it/laboratorija/2021/11/15/news/lietuvoje-pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas-21407670

15.11.2021 / Pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Santaros Klinikos): https://www.santa.lt/naujienos/pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas/

12.11.2021 / Studie untersucht Booster-Effekt (Kölnische Rundschau): Print

12.11.2021 / Uni Köln Studie untersucht Booster-Effekt der Corona-Impfungen (Kölnische Rundschau): Uni Köln: Studie untersucht Booster-Effekt der Corona-Impfungen | Kölnische Rundschau (rundschau-online.de)

09.11.2021 / Studie zur Wirksamkeit der Booster-Impfung (Frankfurt Live): https://www.frankfurt-live.com/studie-zur-wirksamkeit-der-booster-impfung-136942.html

08.11.2021 /Neue Studie startet in Köln Wie gut sind Booster-Impfungen wirklich? (Kölner Stadt-Anzeiger): https://www.ksta.de/koeln/neue-studie-startet-in-koeln-wie-gut-sind-booster-impfungen-wirklich–39112684

03.11.2021 / Alle Infos zur Auffrischung Wann kann ich mir die Booster-Impfung gegen Corona holen? (Kölner Stadt-Anzeiger): Booster-Impfung: Wer braucht die dritte Impfdosis? | Kölner Stadt-Anzeiger (ksta.de)

26.10.2021 / Nach Kimmich-Aussage Was Experten zu Langzeitfolgen der Corona-Impfung sagen (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-kimmich-aussage-was-experten-zu-langzeitfolgen-der-corona-impfung-sagen-39087508

25.10.2021 / Uniklinik Köln sucht Probanden für Drittimpfung (WDR): TV

13.10.2021 / Studie zur Wirksamkeit der Booster-Impfung (Radio Köln): Radio

28.09.2021 / Zu langsam, zu mühsam, zu wenig (SZ): Print

27.09.2021 / Der geringe Beitrag der deutschen COVID-19-Forschung (Tagesspiegel): Print 

16.07.2021 / ECCMID 2021 TV: Talking trials with Oliver Cornely (ECCMID TV): https://www.youtube.com/watch?v=cKRC_2wYXEU

10.07.2021 / Hunderte Kölner trotz zweiter Impfung infiziert (Kölner Stadt-Anzeiger): Print

09.07.2021 / Zu wenig Antikörper? Was wir über die COVID-19-Todesfälle bei geimpften Kölnern wissen? (Kölner Stadt-Anzeiger)

30.06.2021 / Coronavirus: Government advisor part of €12m grant for Covid vaccine research (Cyprus Mail): https://cyprus-mail.com/2021/06/30/coronavirus-government-advisor-part-of-e12m-grant-for-covid-vaccine-research/

27.05.2021 / Aufholjagd: Das europäische Impfstoff-Netzwerk Vaccelerate (ARTE): https://www.arte.tv/de/videos/104080-000-A/aufholjagd-das-europaeische-impfstoff-netzwerk-vaccelerate/

12.05.2021 / Expert says at least one booster vaccine shot necessary (in-Cyprus): https://in-cyprus.philenews.com/expert-says-at-least-one-booster-vaccine-shot-necessary/

11.04.2021 / Pulse of Europe Rheinland: „Europa – Gesundheitspolitik für eine krisenfeste Zukunft?“ (Event): https://www.youtube.com/watch?v=NLR-ELvSyxo

14.03.2021 / 11.111 – VACCELERATE Volunteer Registry (Kölner Universitätsmagazin): https://portal.uni-koeln.de/universitaet/aktuell/koelner-universitaetsmagazin/unimag-einzelansicht/11111

VACCELERATE-related Scientific Publications

10.03.2025 / Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project (JMIR Medical Informatics): https://www.sciencedirect.com/org/science/article/pii/S2291969425000493

01.03.2025 / Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromes (Blackwell Publishing): https://www.sciencedirect.com/science/article/pii/S1198743X24005871

19.12.2024 / Factors that influence recruitment to COVID-19 vaccine trials: a qualitative evidence synthesis (Trials): https://pubmed.ncbi.nlm.nih.gov/39696633/

17.07.2024 / Innovative approaches for vaccine trials as a key component of pandemic preparedness – a white paper (Infection): https://link.springer.com/article/10.1007/s15010-024-02347-1

09.07.2024 / Immunogenicity, reactogenicity and safety of a second booster with BNT162b2 or full-dose mRNA-1273: a randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1-AGED Part B) (Int J Infect Dis.): https://pubmed.ncbi.nlm.nih.gov/38992789/

28.05.2024 / Challenges in assessing the immunization status of adults in Germany—lessons from a population-based VACCELERATE survey on polio vaccination (Infection): https://link.springer.com/article/10.1007/s15010-024-02296-9

25.04.2024 / Coordination of COVID‑19 platform trials in Europe (Trials): https://link.springer.com/epdf/10.1186/s13063-024-08126-5?sharing_token=CVTdqgfhPgvP3eLWTbZq_m_BpE1tBhCbnbw3BuzI2RPA43QxTXTJzEKHg7F__ALEJb0D29J3qOSXX11reLVyoVEgyjF9YzsQPg9zPzE6Cq8Cqzm96oLjtmusdk6eCtROp76kHWqAt0Tuc9nYxbZ6cVmAHXbw4pbpbsoTzZeqF0k%3D

04.04.2024 / Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study (JMIR): https://publichealth.jmir.org/2024/1/e47241

22.12.2023 / Immunogenicity, Reactogenicity and Safety of a Second Booster with BNT162b2 or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1-AGED Part B) (Preprints with The Lancet): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4671824

06.12.2023 / Predicting the next pandemic: VACCELERATE ranking of the World health Organization's Blueprint for action to prevent epidemics (Travel Medicine and Infectious Disease): https://www.sciencedirect.com/science/article/pii/S1477893923001369

29.11.2923 / The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium (vaccines): https://www.mdpi.com/2076-393X/11/12/1784/htm

02.11.2023 / Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time (nature communications): https://www.nature.com/articles/s41467-023-42717-1.pdf

31.10.2023 / Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1) (Vaccine): https://www.sciencedirect.com/science/article/pii/S0264410X23012136

27.10.2023 / Epidemiology of Acute Respiratory Infection with SARS-CoV-2, Influenza A & B Viruses, Respiratory Syncytial Virus, and Adenovirus in VACCELERATE Volunteers in Germany (Preprints with THE LANCET): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4612721

01.09.2023 / Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis (Cochrane Library): https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000065.pub2/full

18.05.2023 / VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe (Vaccine): https://www.sciencedirect.com/science/article/pii/S0264410X23005236

03.04.2023 / Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit (JMIR Publications): https://publichealth.jmir.org/2023/1/e44491

07.12.2022 / Efficacy and safety of COVID‐19 vaccines (Cochrane Library): https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015477/epdf/full

11.2022 / Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination (Journal of Immunological Methods): https://www.sciencedirect.com/science/article/pii/S0022175922001326

10.2022 / Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey (Journal of Infection and Public Health): https://www.sciencedirect.com/science/article/pii/S1876034122002118?via%3Dihub

08.10.2022 / A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network (Trials): https://pubmed.ncbi.nlm.nih.gov/36209129/

04.10.2022 / Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2 (eBioMedicine): https://pubmed.ncbi.nlm.nih.gov/36206622/

19.09.2022 / Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey (Enfermedades Infecciosas y Microbiología Clínica): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534071/

31.08.2022 / Vaccination rates in Europe are not associated with online media intensity (JCOM Journal of Science Communication): https://jcom.sissa.it/archive/21/05/JCOM_2105_2022_A05

18.06.2022 / A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1^st week of July 2022 (Infection): https://link.springer.com/article/10.1007/s15010-022-01931-7

13.06.2022 / Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR (Nature Biotechnology): https://www.nature.com/articles/s41587-022-01347-6

02.06.2022 / VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment (Vaccine): https://www.sciencedirect.com/science/article/pii/S0264410X22006053?via%3Dihub

05.04.2022 / A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern (Communications Medicine): https://www.nature.com/articles/s43856-022-00091-x

23.03.2022 / Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination (Frontiers in Immunology): https://www.frontiersin.org/articles/10.3389/fimmu.2022.845882/full

11.01.2022 / Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis (Cochrane Library): https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000065/full

04.10.2021 / Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days (Frontiers in Immunology): https://www.frontiersin.org/articles/10.3389/fimmu.2021.726960/full

03.08.2021 / Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals (Cell Reports): https://www.cell.com/cell-reports/fulltext/S2211-1247(21)01004-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124721010044%3Fshowall%3Dtrue

29.07.2021 / Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 (The Lancet Infectious Diseases): https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00420-5/fulltext

27.05.2021 / Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS) (The Lancet): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233007/

VACCELERATE Events

VACCELERATE Showcase Event

23 January 2025

VACCELERATE Annual Meeting 

21 January 2025

APT Workshop

18-19 January 2024 Cologne, Germany

ECCMID 2024

27-30 April 2024 Barcelona, Spain

Prof. Bruijning-Verhagen in Cyprus

01 November 2023 Cyprus

It was a great pleasure to host the WP5 Leads of the VACCELERATE pan European Scientific Consortium, Professor Patricia Bruijning-Verhagen and Sanne Hofstraat from the UMC Utrecht, in Cyprus at the Medical School of the European University Cyprus.

The aim of the visit was to perform clinical site visits and interviews with local stakeholders across Cyprus to foster capacity building in the field of clinicaltrials in Cyprus. It was discussed about missed opportunities, the current barriers and possible #acilitators to improve the Cypriot clinical research ecosystem with concrete actions.

Identification of educational needs of Cypriot patients​

The VACCELERATE Cyprus team wants to conduct a study (questionnaire) for the identification of patient advocacy groups educational needs in Cyprus. This study will help EUPATI (European Patient’s Academy on Therapeutic Innovation) Cyprus to create an educational lab based on the official guidelines of EUPATI (central).

KIT 2023 / VACCELERATE Talks and Posters

14-17 June 2023

16th Congress for Infectious Diseases and Tropical Medicine
Leipzig, Germany

Pint of Science / VACCELERATE Talk 

24 May 2023, 19.00 Die Tankstelle, Kyffhäuser Str. 19 50674, Cologne

Tickets (only 2.5€): https://pintofscience.de/event/from-ancient-potatoes-to-future-computers

SCT 44th Annual Meeting

21-24 May 2023 Baltimore, USA

Public Health Conference Timisoara, Romania

11-13 May 2023

Organized by the Regional Center of Public Health Timisoara, EPIVEST Association and the University of Medicine and Pharmacy Timisoara.

The conference targeted public health specialists from the regional public health authorities, medical schools and hospitals. 

https://epivest.ro/conferinta-nationala-de-sanatate-publica-tm-2023/

CECAD Open Day

06 May 2023, 10.00-17.00

Visit our VACCELERATE booth, special campagin with the Vacuna vaccination app (https://vacuna.io/)

Programme: https://www.cecad.uni-koeln.de/tag-der-alternsforschung

ECCMID 2023

33rd European Congress of Clinical Microbiology & Infectious Diseases

 15 – 18 April 2023 Copenhagen, Denmark

2nd VACCELERATE Annual Meeting 16 MARCH 2023

1st Scientific Meeting of the National CY Vaccination Committee 

22 October 2022, Cyprus

MYK 2022

12-14 September 2022 Vienna, Austria

CZECRIN Annual Research Conference 2022 

09 JUNE 2022 Brno, Czech Republic

International Clinical Trials Day (ICTD) 2022

17 MAY 2022 Berlin, Germany

FAMHP Vaccine Symposium

10 May 2022

Prof. Pierre Van Damme presenting VACCELERATE in his talk „Perspective for the future: Vaccinopolis and biopreparedness initiative“

40th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) 

09-13 MAY 2022 Athens, Greece

23-26 APRIL 2022

32nd European Congress of Clinical Microbiology & Infectious Diseases, Lisbon, Portugal

1st Cypriot-Greek VACCELERATE Volunteer Registry Webinar with local National Patient Advocacy Groups 28 MARCH 2022

– To seek the support of PAG Members in completing the VAC PAG questionnaire (perspectives of PAGs for participation in clinical trials and volunteer registries)

– To invite them to join the VACCELERATE Volunteer Registry by becoming volunteers in our Cypriot Greek VAC platforms More than 12 PAGs participated

You can watch the video of the webinar (in Greek) here: https://www.youtube.com/watch?v=DNFNVe17mtg

The First World Conference Fighting COVID-19 Pandemic Health Challenges

26-28 MARCH 2022, Belgrade, Serbia.

VACCELERATE talk: Jon Salmanton-García: VACCELERATE: The pan-European backbone for the acceleration of phase 2 & 3 COVID-19 vaccine trials

1st VACCELERATE Annual Meeting 09-10 MARCH 2022

With a keynote lecture by top leading expert Stephen Lockhart  from Pfizer:
Vaccine Clinical Trials: Key Factors for Success – BNT162 as an Example.